BenzingaOctober 19, 2026 at 10:50 AM NY8 Days Ago
Barclays Maintains Equal-Weight on Amrize, Lowers Price Target to $40
Barclays analyst Adam Seiden maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $55 to $40.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
